Standout Papers

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia 1995 2026 2005 2015 5.7k
  1. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia (1995)
    James Shepherd, Stuart M. Cobbe et al. New England Journal of Medicine
  2. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein (2008)
    Paul M. Ridker, Eleanor Danielson et al. New England Journal of Medicine
  3. Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein (2009)
    Paul M. Ridker, Eleanor Danielson et al. Obstetrical & Gynecological Survey
  4. Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease (2005)
    John C. LaRosa, Scott M. Grundy et al. New England Journal of Medicine
  5. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial (2002)
    James Shepherd, Gerard J. Blauw et al. The Lancet
  6. Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study (2003)
    Naveed Sattar, Allan Gaw et al. Circulation
  7. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial (2009)
    Paul M. Ridker, Eleanor Danielson et al. The Lancet
  8. Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) (2001)
    A. Michael Wallace, Alex D. McMahon et al. Circulation
  9. Pravastatin and the Development of Diabetes Mellitus (2001)
    Dilys J. Freeman, John Norrie et al. Circulation
  10. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study (2007)
    Scott Brouilette, J. Moore et al. The Lancet
  11. A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism (2009)
    Robert J. Glynn, Eleanor Danielson et al. New England Journal of Medicine
  12. Effects of Dietary Polyunsaturated and Saturated Fat on the Properties of High Density Lipoproteins and the Metabolism of Apolipoprotein A-I (1978)
    James Shepherd, Christopher J. Packard et al. Journal of Clinical Investigation

Immediate Impact

3 by Nobel laureates 5 from Science/Nature 224 standout
Sub-graph 1 of 14

Citing Papers

The changing landscape of atherosclerosis
2021 StandoutNature
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
72 intermediate papers

Works of James Shepherd being referenced

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
and 18 more

Author Peers

Author Last Decade Papers Cites
James Shepherd 19575 10798 5681 8070 173 32.3k
Neil J. Stone 18539 13998 6219 14922 187 44.0k
Kalevi Pyörälà 12439 14694 3546 12496 227 33.4k
Philip J. Barter 20207 16133 2611 7888 379 35.4k
Anthony Keech 14594 7422 4895 6670 292 23.9k
Terje R. Pedersen 16286 7655 5313 7995 168 24.4k
Donald B. Hunninghake 11083 9241 3431 7363 167 25.9k
Alberico L. Catapano 14340 8163 3276 7003 628 28.9k
Anders Olsson 14560 7434 4088 5969 282 23.0k
Richard C. Pasternak 11294 9189 3406 9750 91 27.7k
Erik S.G. Stroes 13344 6575 2119 7919 490 28.5k

All Works

Loading papers...

Rankless by CCL
2026